HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Despite lack of conclusive data, survivorship care plans remain an ‘important tool’ Jennifer R. Southall
-
- Should the development and use of survivorship care plans still be encouraged?
- Learning to manage with less John Sweetenham, MD, FRCP, FACP
- Work-life balance for APPs who are parents in the era of COVID-19 Jaime Shahan, PA-C
- Secondary cytoreductive surgery prolongs PFS among women with recurrent ovarian cancer Jennifer R. Southall
- CV matrix aims to improve gender equity by ‘accounting for COVID time’ Alexandra (Sasha) Todak
- Hospital-acquired COVID-19 linked to increased mortality among patients with cancer John DeRosier
- Ethnic minorities, patients with cancer at higher risk for COVID-19, app-based study shows John DeRosier
- Ivosidenib plus venetoclax with or without azacitidine safe, effective for AML subset Drew Amorosi
-
- Pemetrexed appears safe for maintenance therapy with pembrolizumab in metastatic nonsquamous NSCLC Drew Amorosi
- Intratumoral mRNA-2416 monotherapy appears safe for patients with solid tumors Jennifer R. Southall
- Tumor rupture linked to worse outcomes among patients with GIST Jennifer R. Southall
- Emergency surgery linked to higher risk for venous thromboembolism Jennifer R. Southall
- FDA approves Inqovi as at-home treatment for myelodysplastic syndrome